Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

34

Number of overlapping holdings

34.7%

% of WDNA's 99 holdings also in GNOM

82.9%

% of GNOM's 41 holdings also in WDNA

Overlap by Weight
Sector Drift (WDNA minus GNOM)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in WDNA
Weight
in GNOM
Overlap
GILEAD SCIENCES INC 2.1% 2.4% 2.1%
VERTEX PHARMACEUTICALS INC 2.4% 2.0% 2.0%
AGILENT TECHNOLOGIES INC 1.9% 4.5% 1.9%
ALNYLAM PHARMACEUTICALS INC 1.8% 4.2% 1.8%
SAREPTA THERAPEUTICS INC 1.8% 4.0% 1.8%

Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to GNOM
ASTRAZENECA PLC-SPONS ADR 2.9%
ARCHER-DANIELS-MIDLAND CO 2.2%
PFIZER INC 2.1%
ELI LILLY & CO 2.0%
CORTEVA INC 2.0%
MERCK & CO. INC. 2.0%
THERMO FISHER SCIENTIFIC INC 1.9%
REGENERON PHARMACEUTICALS 1.9%
BIOGEN IDEC INC 1.9%
DANAHER CORP 1.8%
WDNA Underweight Relative to GNOM
10X GENOMICS INC CLASS A -4.7%
CRISPR THERAPEUTICS AG -3.4%
INTELLIA THERAPEUTICS, INC. -3.4%
GENSCRIPT BIOTECH CORPORATION -3.4%
BIONTECH SE SPONSORED ADR -3.3%
ARROWHEAD PHARMACEUTICALS, INC. -3.2%
BIO-TECHNE CORPORATION -3.2%
BEAM THERAPEUTICS, INC. -3.1%
ULTRAGENYX PHARMACEUTICAL IN -3.1%
PACIFIC BIOSCIENCES OF CALIF -3.0%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY